Out of the 14 analysts covering the stock, only two have buy ratings while six have sell ratings, and another six have hold ratings. The average share price target of the stock signals a downside potential of 25% from the current market price.
Fundamental Radar: Why KEI Industries could surpass October highs to hit record in next 12 months?
KEI Industries is a leading player in the wires and cables (W&C) space with an extensive product portfolio and distribution reach with PAN India presence. KEI ranks among the top three wires and cables (W&C) manufacturers in the country. It services retail and institutional customers.
Golden Crossovers: These 4 stocks signal further bullishness
In the NSE list of stocks, 4 stocks with a market cap of over Rs 100 crore are witnessing Golden Crossovers, according to stockedge.com’s technical scan data. Golden Cross is an important technical indicator of bullishness. It occurs when the short-term moving average crosses over the major long-term moving average Continue Reading
Big Movers on D-St: What should investors do with RVNL, IRFC and HDFC Life?
Stocks that were in focus include names like RVNL which was up over 5%, IRFC which closed with gains of nearly 6% and HDFC Life which rose more than 4% on Thursday.
At multi-year highs: These 4 stocks gave 5-year breakouts
In the NSE list of stocks with a market cap of over Rs 1,000 crore, four stocks crossed their previous 5-year high value at the close on November 24, suggesting bullishness in counters, according to stockedge.com’s technical scan data. Take a look:
Stocks to buy or sell today: 12 short-term trading ideas by experts for 25 November 2022
The S&P BSE Sensex and Nifty50 were hovering near new lifetime highs on Thursday.
What changed for market while you were sleeping
Nifty futures on the Singapore Exchange traded 40.5 points, or 0.22 per cent, lower at 18,627.50, signaling that Dalal Street was headed for a negative start on Friday.
Stocks in the news: Lupin, Biocon, PNB, Lauras Labs, PTC India and SJVN
The USFDA has issued 8 observations for the drug product facility and API facility at Mandideep. The US drug regulator has inspected company’s Mandideep unit-1 facility during November 14-23, 2022.
Time has come to review monetary policy objectives: RBI deputy governor Michael Patra
Formulating monetary policy has become more challenging in the current environment because of data lags and also frequent reviews, Patra said. “On the basis of data one month and three months ago, I will have to assess what inflation and growth are going to be one year down the line,” Continue Reading
Cash is still king in rural India, UPI favourite in metros
Top bankers say that cash withdrawal from ATMs slowed down in major cities, as payments through UPI (united payments interface) have clearly taken over. However, ATMs are still very relevant for cash customers in India, especially in the tier-2 to tier-6 towns.